CXCR1 and non-small cell lung carcinoma: Furthermore, by simultaneously blocking the CXCR1/2-dependent import of immunosuppressive MDSCs, combination inhibition of SHP2 and CXCR1/2 may enhance antitumor T cell responses in NSCLC (74).